GRCE

Conviction 4HealthcareScan · Thu, Jun 25, 2026

GRCE$2.37+1.72%

ResistanceSupportVol 14

Vol MA14 245.37K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Grace Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.gracetx.com ↗

Price2.37

Change+1.72%

Gap+0.86%

Rel volume0.79×

Avg volume270.58K

Avg $ vol643.46K

SMA 202.36

SMA 502.57

SMA 2003.29

Price vs 50-7.65%

Price vs 200-27.87%

MA stackbearish

50/200 cross—

Supertrenddown · 2.66

RSI (14)49

MACD hist0.03

MACD cross—

Stoch %K / %D62 / 56

ADX (14)13

+DI / −DI19 / 18

RSI divergence—

MACD divergence—

ATR %+7.01%

ADR %6.47%

52w high5.13

52w low2.10

From 52w high-53.80%

Above 52w low+12.86%

New 52w highNo

SqueezeOn · 8d

Bollinger width20.79%

%B0.53

Donchian pos41.38%

Donchian high2.71

Donchian low2.13

AVWAP (52w high)3.07

vs AVWAP high-22.77%

AVWAP (52w low)2.46

vs AVWAP low-3.61%

OBV trendFlat

Chaikin MF (20)-0.01

Today vs 20d0.79×

Avg vol (14d)245.37K

Avg vol (20d)270.58K

Avg $ vol (20d)643.46K

Market cap38.57M

RS 3m (vs SPY)-59.78%

RS 6m (vs SPY)-39.21%

RS line new highNo

Trend template1/8

Technical rank27.9

1 week+6.76%

1 month+0.42%

3 months-49.47%

6 months-31.30%

1 year-21.00%

YTD-35.25%

P/E-4.95

P/B0.60

P/S0.39

P/FCF-4.20

EPS-0.4700

Div yield—

ROE-12.20%

ROA-11.69%

Debt/Eq—

Current8.10

EV/EBITDA—

Gross margin—

Net margin-7.79%

Rev growth—

EPS growth18.55%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value21.59M

Revenue—

Net income-2.31M

Gross profit—

Free cash flow-9.19M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out15.47M

Employees6

ListedTue, Apr 26, 2011

Free float8.3M

Float %53.7%

Short interest2.02M

Days to cover6.7d

Short volume61.5%

Squeeze score79 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank27.9 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.64

Support2.11

Days since event—

Candle confirm—

News sentiment—

Financials as of Wed, Dec 31, 2025 · quarterly.

Congress activity

Disclosed STOCK Act trades in GRCE

All disclosures →

No recent disclosed trades by Congress in GRCE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GRCE

No recent insider (Form 4) filings in GRCE. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GRCE · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.